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Abstract
Background: In HIV-infected T lymphocytes, NF-κB/Rel transcription factors are major elements
involved in the activation of LTR-dependent transcription from latency. Most NF-κB heterodimer
p65/p50 is sequestered as an inactive form in the cytoplasm of resting T lymphocytes via its
interaction with IκB inhibitors. In these cells, both absolute HIV latency and low level ongoing HIV
replication have been described. These situations could be related to differences in the balance
between NF-κB and IκBα ratio. Actually, control of IκBα by cellular factors such as Murr-1 plays
a critical role in maintaining HIV latency in unstimulated T lymphocytes. Formerly, our group
demonstrated the presence of nuclear IκBα in T cells after PMA activation. Now we attempt to
determine the dynamics of NF-κB/IκBα nucleocytosolic transport in absence of activation as a
mechanism to explain both the maintenance of latency and the existence of low level ongoing HIV
replication in resting CD4
+ T lymphocytes.
Results and conclusion: We show that the inhibition of the nuclear export by leptomycin B in
resting CD4
+ T cells resulted in nuclear accumulation of both IκBα and p65/RelA, as well as
formation of NF-κB/IκBα complexes. This proves the existence of a rapid shuttling of IκBα
between nucleus and cytosol even in absence of cellular activation. The nuclear accumulation of
IκBα in resting CD4
+ T lymphocytes results in inhibition of HIV-LTR dependent transcription as
well as restrains HIV replication in CD4
+ T lymphocytes. On the other hand, basal NF-κB activity
detected in resting CD4
+ T lymphocytes was related to low level HIV replication in these cells.
Background
The nuclear factor κB (NF-κB) family of proteins are
inducible transcription factors that play a central role in
regulating the expression of a wide variety of genes associ-
ated with cell proliferation, immune response, inflamma-
tion, cell survival, and oncogenesis [1,2]. Functionally
competent NF-κB is mainly composed by heterodimers of
p65/RelA or c-Rel proteins complexed to p50/NF-κB1.
NF-κB activity is regulated partially at subcellular level
because active NF-κB heterodimers are normally seques-
tered in the cytoplasm via its non-covalent interaction
with a family of inhibitory proteins termed IκBs, being
IκBα the major NF-κB inhibitor protein. NF-κB activation
is initiated by a variety of stimuli such as cytokines and
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growth factors, which lead to activation of IκB kinase
complex (IKK). IKK in turn phosphorylates IκBα, result-
ing in its degradation via the ubiquitin-mediated proteo-
lytic pathway. This permits NF-κB translocation into the
nucleus, where engages cognate κB enhancer elements
and modulates gene expression [1,2].
Control over NF-κB activity is not only accomplished
through association with IκBα in the cytosol, but a role for
nuclear IκBα in the control of NF-κB-driven transcription
has been proposed [3,4]. In this model, newly synthesized
IκBα would be able to shuttle actively between the cyto-
plasm and the nucleus, and then remove NF-κB from the
-κB consensus sequences. Thus, nuclear IκBα would pro-
mote the return of NF-κB to the cytoplasm and the termi-
nation of its transcriptional response. The shuttle of NF-
κB and IκBα between nucleus and cytosol in tumor cell
lines has been described previously [3-5] as well as its
influence on -κB dependent gene expression. However, in
normal human CD4
+ T lymphocytes in a resting state, NF-
κB binding activity is low and consists predominantly of
inactive p50/p50 homodimers. In these cells, functional
p50/p65 complexes are induced by cell activation [6]. Our
group described previously that IκBα can translocate to
the nucleus in T lymphocytes activated with phorbol-12-
myristate-13-acetate (PMA) [7], but little is known about
the existence of a NF-κB/IκBα shuttling in resting blood T
cells.
The NF-κB pathway provides an attractive target to viral
pathogens. Activation of NF-κB is a rapid, immediate early
event that occurs within minutes after exposure to a stim-
ulus, does not require de novo protein synthesis, and pro-
duces a strong transcriptional activation of several viral
genes [6]. As a result, NF-κB is essential in the regulation
of the HIV-1 long terminal repeat (LTR) promoter [8-10].
The promoter-proximal (enhancer) region of the HIV LTR
contains two adjacent NF-κB binding sites (-109 to -79)
that play a central role in mediating inducible HIV gene
expression. These NF-κB responsive elements are major
elements in triggering HIV LTR-transcription in blood
CD4
+ T cells [6,9-11]. Accordingly, HIV production in T
cells is mainly associated with the activation induced by
different stimuli, whereas resting or unstimulated CD4
+ T
lymphocytes offer a cellular environment for latency due
to low permissiveness to HIV LTR activity [6]. However,
the existence of a low-level ongoing replication in resting
CD4
+ T lymphocytes has been described [12-14].
To reconcile these contradictory data, the hypothesis that
the existence of a basal NF-κB activity could contribute to
the low viral replication detected in HIV-infected CD4
+ T
lymphocytes in a resting state is proposed. To this aim, the
molecular mechanisms involved in the NF-κB/IκBα traffic
between cytoplasm and nucleus of resting T lymphocytes
from human blood have been analyzed. When resting
CD4
+ T lymphocytes were cultured in presence of lepto-
mycin B (LMB), a nuclear export inhibitor [15], both p65/
RelA and IκBα were accumulated and associated in the
nucleus, suggesting a rapid shuttling of both proteins in
unstimulated T cells. In fact, HIV LTR-driven transactiva-
tion and HIV replication can be blocked in resting as well
as activated T cells by IκBα over-expression. Our findings
suggest that the balance between NF-κB and IκBα at
nuclear level would be a key mechanism involved in both
the maintenance of HIV latency and the induction of low-
level HIV replication in resting CD4
+ T lymphocytes.
Results
Analysis of IκBα and p65/RelA subcellular distribution in 
resting CD4
+ T lymphocytes
Resting non-activated CD4
+  T lymphocytes were nega-
tively isolated from human PBMCs by depletion of B cells,
NK cells, monocytes, CD8 
+ T cells and activated lym-
phocytes. Analysis by flow cytometry revealed they were
CD4
+ CD25 
- CD69 
- HLA-DR- with a purity >95%.
IκBα and p65/RelA shuttling between nucleus and cytosol
was analyzed in resting blood CD4
+ T cells by using LMB,
a specific inhibitor of the nuclear protein export. The sub-
cellular distribution of IκBα and p65/RelA was first ana-
lyzed by immunofluorescence assays. Both IκBα and p65/
RelA were localized in the cytosol of unstimulated CD4
+ T
cells (Fig. 1), but after treatment with LMB, both IκBα and
p65/RelA were retained in the nucleus. This nuclear trans-
location was observed in the absence of any stimulus and
was not due to serum activation since similar results were
observed in serum deprivation conditions (data not
shown).
These results were confirmed using chimeric proteins
formed by the enhanced yellow fluorescent protein
(EYFP) fused to IκBα or p65/RelA. Resting CD4
+ T cells
were transiently transfected with plasmids pEYFP-p65 and
pEYFP-IκBα separately. Analysis was performed 24 hours
after transfection by confocal microscopy. There was low
quantity of both IκBα and p65/RelA in the nucleus of the
resting T cells before LMB treatment (Fig. 2a) but after
exposure to LMB, both EYFP-IκBα and EYFP-p65 fusion
proteins were retained in the nucleus. Plasmid pEYFP-C1
containing the EYFP under the control of CMV promoter
was used as control of non-specific intracellular distribu-
tion.
To exclude that nucleoporation could induce NF-κB activ-
ity, electrophoretic mobility shift assays (EMSA) were per-
formed in nuclear extracts from CD4
+  T lymphocytes
transfected with a control plasmid (pcDNA3.1) by two
different methods: the Amaxa Nucleofector system andRetrovirology 2007, 4:56 http://www.retrovirology.com/content/4/1/56
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classical electroporation using an Equibio electroporator
(Figure 2b).
In order to determine the dynamics of IκBα shuttling, rest-
ing CD4
+ T cells were transiently transfected with EYFP-
IκBα vector, attached to fibronectine-coated slides and
filmed in vivo by time-lapse confocal microscopy during
treatment with LMB. Photographs were taken each minute
after adding LMB and it was determined that less than 6
minutes were enough to saturate the nucleus with IκBα
(Fig. 3 and additional file 1).
LMB toxicity was assessed by propidium iodide staining
and flow cytometry in resting CD4
+ T cells treated up to 24
hours. Mortality due to LMB treatment (20 nM) was
increased only 10% above controls after the longest incu-
bation time (data not shown).
Analysis of nuclear protein-protein interactions
Because more than 108 blood T lymphocytes for each
experimental point were required to perform these exper-
iments, T cells were expanded according to a protocol pre-
viously developed in our laboratory. PBMCs were
cultured for 3 days with 5 µg/ml PHA and for the consec-
utive 9 days with 300 U/ml IL-2. These long-term cultures
of PHA-treated T lymphocytes were maintained without
supplemental IL-2 18 hours before the experiment to
assure they were in a resting state concerning NF-κB activ-
ity. Following this protocol, it was proved that basal and
induced NF-κB was similar as in resting T lymphocytes [7]
(see Additional file 2).
Consequently, association between IκBα and p65/RelA
was determined in the nucleus of long-term cultures of
PHA-treated T lymphocytes. For this purpose, nuclear and
Subcellular localization of IκBα and p65/RelA in CD4
+ T lymphocytes Figure 1
Subcellular localization of IκBα and p65/RelA in CD4
+ T lymphocytes. Cells were treated or not with 20 nM LMB and 
then fixed, permeabilized and stained with specific antibodies against IκBα and p65/RelA. A secondary antibody conjugated 
with Texas Red (Molecular Probes) was used. Images were taken by confocal microscopy.
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cytosolic protein extracts were analyzed by immunoblot-
ting assays. As previously shown for resting CD4
+ T lym-
phocytes (Fig. 1), both nuclear IκBα and p65/RelA levels
increased in cells treated with LMB (Fig. 4a, Nucleus, lane
2). The accumulation of cytosolic proteins in the nucleus
after LMB treatment has been ruled out by immunoblot-
ting of cytosolic and nuclear extracts from PHA-treated T
cells by using an antibody against both p105 and p50/NF-
κB1 proteins (Fig. 4b). The p105 protein is the precursor
of the p50 subunit and it presents exclusively a cytosolic
location.
Immunoprecipitation assays with an antibody against
p65/RelA showed the presence of NF-κB/IκBα complexes
in the nucleus of T cells treated or not with LMB (Fig. 4a,
Immunoprecipitation, Nucleus, lanes 1 and 2), whereas
no association between p65/RelA and IκBα was observed
in cells activated with PMA (Fig. 4a, Immunoprecipita-
tion, Nucleus, lane 3).
NF-κB DNA-binding activity in unstimulated T 
lymphocytes
Once it was confirmed that both p65/RelA and IκBα were
able to shuttle between nucleus and cytosol in unstimu-
lated T cells, NF-κB DNA binding activity was analyzed by
EMSA. Despite the presence of p65/RelA in the nucleus,
no binding was detected in unstimulated T cells treated or
not with LMB (Fig. 4c, lanes 1 and 2). This correlated with
the detection of NF-κB/IκBα complexes in the nucleus of
these cells (Fig. 4a, Immunoprecipitation, Nucleus, lanes
Subcellular localization of EYFP-IκBα and EYFP-p65 fusion proteins in CD4
+ T lymphocytes Figure 2
Subcellular localization of EYFP-IκBα and EYFP-p65 fusion proteins in CD4
+ T lymphocytes. (a) Cells were tran-
siently transfected with 1 µg of either EYFP-IκBα or EYFP-p65 expression vectors per million of cells. LMB was added immedi-
ately after transfection. After 18–24 hours of incubation, cells were analyzed by confocal microscopy. pEYFP-C1 vector was 
used as control of unspecific distribution. (b) Resting purified CD4
+ T lymphocytes were transiently transfected with the con-
trol plasmid pcDNA3.1 by using an Amaxa nucleofector and a classical electroporator (Equibio). As occurs in untransfected 
resting T cells (lane 1), NF-κB was not induced in resting CD4
+ T lymphocytes after electroporation (lanes 3 and 4). As a posi-
tive control, NF-κB (p50/p65) binding was induced in these cells by PMA activation (lane 2).
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1 and 2). As expected, NF-κB kept the binding activity to -
κB motif in PMA-activated T cells (Fig. 4c, lane 3), due to
the absence of NF-κB/IκBα complexes in the nucleus of
these cells (Fig. 4a, Immunoprecipitation, Nucleus, lane
3).
Analysis of IκBα resynthesis in resting T cells
Unstimulated T cells were incubated with CHX for 30
minutes before adding other stimulus in order to stop de
novo protein synthesis. Then, LMB or PMA were added to
the culture medium. Immunoblotting assays showed a
decrease of IκBα levels in the nucleus of T cells incubated
with both CHX and LMB (Fig. 4d, lane 2) or with CHX,
LMB and PMA (Fig. 4d, lane 3), but not in those cells only
incubated with LMB (Fig. 4d, lane 1). These data not only
confirm previous results showing that nuclear transloca-
tion of IκBα is dependent on protein resynthesis [3] but
also asserts that this de novo protein synthesis is carried out
even in unstimulated T cells.
Basal NF-κB activity can activate HIV-LTR promoter in 
CD4
+ T lymphocytes
Resting blood CD4
+ T cells were transfected with a LTR-
LUC vector alone or together with a Tat expression vector
under the control of the CMV promoter in order to assess
NF-κB-dependent transcriptional activity in these cells by
measurement of luciferase activity (Fig. 5a and 5b). As
expected, both Tat over-expression and PMA activation
enhanced LTR-dependent transcription, as previously
described [11,16]. However, when nuclear levels of IκBα
were increased by LMB (Fig. 5a) or transient transfection
of CMV-IκBα vector (Fig. 5b), a dramatic decrease in luci-
ferase activity was observed, both in PMA-activated T cells
and cells in which Tat was over-expressed. Interestingly, a
basal NF-κB activity able to induce a low LTR transactiva-
tion was detected in unstimulated CD4
+ T cells. This low
LTR transactivation was annulled when IκBα was over-
expressed by both LMB or CMV-IκBα transfection, thus
proving this basal LTR transactivation was due to a resid-
ual NF-κB activity in resting CD4
+ T cells.
Progression of HIV replication in resting CD4
+ T 
lymphocytes
To assess the role of basal NF-κB activity and IκBα over-
expression on a model of HIV production in resting and
activated CD4
+ T cells, highly purified CD4
+ CD25 
- CD69 
-
DR-  T lymphocytes obtained from blood of different
healthy donors were transfected with a full-length infec-
tious HIV clone (NL4.3) together with a CMV-IκBα
expression vector or pcDNA3 as negative control. Cells
were maintained in culture up to 7 days either in the
absence of activation or activated with two different stim-
uli, PHA and CD3 antibodies. HIV p24-gag was quantified
5 and 7 days after transfection. An intense HIV replication
was detected in activated CD4
+ T cells after 7 days in cul-
ture (Fig. 6b). Besides, a discrete but significant HIV p24-
gag production was assessed in resting CD4
+ T cells after 5
days of transfection (Fig. 6a). When IκBα was over-
expressed in these cells, p24-gag production decreased as
compared to cells transfected with a control plasmid and
this difference was significant (p < 0.05) for resting and
anti-CD3 activated T cells. Although more than five-fold
decrease was observed at day 7 for PHA-activated lym-
phocytes when IκBα was over-expressed, this result did
not reach statistical significance (p = 0.081).
Discussion
Initiation of HIV transcription from a quiescent state is
regulated through the concerted action of different cellu-
lar factors acting at LTR sequences [17,18]. Among them,
NF-κB proteins are the most important inducible ele-
ments involved in initiation of HIV transcription in nor-
mal T cells [6,11,19-21]. As a result, a strong control of
nuclear NF-κB translocation would be required to main-
tain HIV latency.
Nuclear translocation and activity of NF-κB is regulated
through different mechanisms including association with
its main inhibitor IκBα as a cytosolic inactive form. An
additional mechanism of NF-κB control is the nuclear
location of IκBα that act as a terminator of -κB dependent
transactivation [4,5]. In fact, a dynamic shuttling of NF-κB
has been described in established cell lines by balancing
fluxes into and out of the nucleus [22-24] as well as the
capacity of IκBα to enter the nucleus of T cells activated
with PMA [7]. However, the nucleocytosolic shuttling of
Kinetic analysis of nuclear IκBα translocation Figure 3
Kinetic analysis of nuclear IκBα translocation. One 
CD4
+ T lymphocyte transfected with EYFP-IκBα vector was 
photographed before and after treatment with LMB up to 30 
minutes. Photographs were taken in vivo by confocal micros-
copy every minute after adding LMB.
t=0' t=1' t=3' t=6'
t=9' t=14' t=17' t=30'Retrovirology 2007, 4:56 http://www.retrovirology.com/content/4/1/56
Page 6 of 13
(page number not for citation purposes)
both NF-κB and IκBα in T cells in a resting state and its
potential role in the maintenance of latency or the initia-
tion of HIV transcription has not been determined so far.
This is a very important issue, because resting CD4
+ T cells
containing integrated HIV provirus constitute one of the
long-lived cellular reservoirs of HIV in vivo [25,26] and
represent a main obstacle to the eradication of the virus
[27,28]. This HIV reservoir had been thought to be quies-
cent with regard to virus replication based on the principle
that HIV production in T cells is linked to cellular activa-
tion. However, HIV production may occur in T cells that
have not undergone classic T cell activation [29] and even
in CD4
+ T lymphocytes lacking any activation markers
[13].
Analysis of nuclear NF-κB/IκBα complexes in CD4
+ T cells and IκBα pool dependence on de novo protein synthesis Figure 4
Analysis of nuclear NF-κB/IκBα complexes in CD4
+ T cells and IκBα pool dependence on de novo protein syn-
thesis. (a) Analysis of subcellular distribution of p65/RelA and IκBα in CD4
+ T cells and presence of NF-κB/IκBα complexes in 
the nucleus after treatment with LMB or PMA. Ten micrograms of cytosolic and nuclear extracts from CD4
+ T cells treated 
with either PMA or LMB during 4 and 6 hours respectively were analyzed by Western Blot using antibodies against p65/RelA 
and IκBα. Immunoprecipitation assays were performed using 100 µg of these cytosolic and nuclear extracts, which were incu-
bated with 5 µg of an antibody against p65/RelA conjugated with agarose. IκBα and p65/RelA complexes were characterized by 
immunoblotting. (b) Contamination with cytosolic proteins during nuclear protein extraction or accumulation of cytosolic pro-
teins in the nucleus after treatment with LMB was assessed by Western Blot using an antibody against both p105 and p50/NF-
κB1 proteins. (c) Analysis of NF-κB DNA-binding activity in CD4 
+T cells treated with either PMA or LMB. Three micrograms 
of nuclear extract were incubated with an oligonucleotide containing the double consensus motif κB present in the HIV LTR 
labeled with [α-32P]-dCTP. Protein extracts were obtained from CD4
+ T cells after treatment with either LMB or PMA for 6 
and 4 hours respectively. (d) Analysis of IκBα pool dependence on de novo protein synthesis. Ten micrograms of nuclear 
extracts from CD4
+ T cells incubated with 20 nM LMB for 4 hours and 10 µg/ml CHX and/or 25 ng/ml PMA for 4 hours,30 min 
and 2 hours, respectively, were analyzed by Western Blot.
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These observations raise the question of whether NF-κB
would be able to initiate the transcription of its target
genes in resting T cells. In normal human CD4
+ T cells, NF-
κB binding activity is low and consists predominantly of
p50/p50 complexes, but not p50/p65. T-cell activation
results in the formation of p50/p65 complexes and the
induction of HIV-LTR transactivation. According to this
hypothesis, both p65/RelA and IκBα showed a predomi-
nant cytosolic distribution in resting CD4
+ T cells (Fig. 1).
However, a sharp increase in both nuclear IκBα and p65/
RelA was found when nuclear export was inhibited by
LMB, even in the absence of activation (Fig. 1 and 2).
Moreover, in vivo kinetic studies determined that IκBα
completely filled the nucleus of resting CD4
+ T cells in less
than 6 minutes after adding LMB to the culture medium
(Fig. 3 and additional file 1). NF-κB was associated to
IκBα in the nucleus of resting T cells (Fig. 4a) and only
p50/p50 heterodimers were able to bind DNA (Fig. 4c). In
contrast, in PMA-activated T cells no association between
IκBα and p65/RelA was found despite the presence of
both proteins in the nuclear compartment (Fig. 4a), and
consequently p50/p65 heterodimers could bind DNA
(Fig. 4c). These results suggest the existence of post-trans-
lational modifications in p65/RelA and/or IκBα in PMA-
activated T lymphocytes that would decrease the affinity
between both proteins allowing DNA binding of active
NF-κB. On the other hand, it has been described that only
newly synthesized IκBα can enter the nucleus [4]. Accord-
ingly, a sharp decrease in nuclear IκBα levels was observed
in resting T cells when de novo protein synthesis was inhib-
ited, whereas p65/RelA exhibited a longer half-life due to
the existence of a pre-synthesized pool or a less active deg-
Influence of IκBα over-expression on HIV-LTR transactivation Figure 5
Influence of IκBα over-expression on HIV-LTR transactivation. Resting CD4
+ T cells were transfected with LTR-LUC 
vector together with (a) pcDNA3.1 and/or CMV-Tat expression vectors or (b) pcDNA3.1 and/or CMV-Tat and/or CMV-IκBα 
expression vectors, as indicated. Cells were treated with LMB immediately after transfection and/or with PMA two hours after 
transfection, as indicated. Luciferase activity was measured 18 hours after transfection. Numbers on the top of the bars repre-
sent fold transcriptional activity relative to unstimulated T cells transfected with pcDNA3.1.
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radation (Fig. 4d). Therefore, a rapid degradation of IκBα
occurs in T cells in the absence of activation and continu-
ous synthesis is required to maintain a cytosolic pool of
dissociated IκBα, able to translocate to the nucleus and
capture NF-κB. These data proved not only the existence
of a nucleocytosolic shuttling of IκBα and NF-κB in rest-
ing T lymphocytes but also that it is an extremely dynamic
process detected exclusively when nuclear export is inhib-
ited.
It has been described that HIV replication may occur
within CD4
+ T cells activated below the threshold required
for proliferation [12,13]. Indeed, it has been proposed
that basal nuclear NF-κB translocation is required for the
activation of genes involved in cell survival and these
small discharges of nuclear NF-κB could be the cause of
the low level replication observed in resting HIV-infected
T cells. In support of this hypothesis, when CD4
+ T cells
were transfected with luciferase expression vectors under
the control of the HIV-LTR, low but consistent transcrip-
tional activity, which was enhanced by Tat expression, was
detected (Fig. 5a). In order to confirm that NF-κB was
responsible for this low level LTR activity in resting T cells,
nuclear levels of IκBα were increased by LMB (Fig. 5a) or
transient transfection of CMV-IκBα vector (Fig. 5b). In
both cases, LTR transcriptional activation decreased, even
when Tat was also over-expressed. Moreover, despite the
observation that in PMA-activated lymphocytes NF-κB
was not bound to IκBα in the nucleus (Fig. 4a), IκBα over-
expression resulted in strong decrease in HIV-LTR transac-
tivation. It has been previously shown [3,4] that IκBα can
bind p65/RelA and transport it back to the cytosol. When
this pathway is blocked by LMB, IκBα cumulates in the
nucleus at higher concentrations than during normal traf-
ficking. We hypothesize that in these conditions NF-κB
activity could be inhibited by high IκBα concentrations
(Fig. 5). This observation supports that mechanisms
involved in post-translational modifications of p65/RelA
and/or IκBα induced by PMA, which block the formation
of NF-κB/IκBα complexes, can be overcome by IκBα over-
expression. Besides, low LTR transactivation detected in
resting CD4
+ T cells was also annulled by IκBα over-
expression, proving this basal LTR transactivation was due
to a residual NF-κB activity in these cells.
To confirm the role of IκBα in an infectious model, a full-
length proviral clone (NL4.3) was transfected in non-
stimulated CD4
+ T cells together with a CMV-IκBα expres-
sion vector or pcDNA3.1 as negative control. This trans-
fection method was used because the main goal was to
analyze the role of IκBα over-expression on HIV replica-
tion in both resting and activated lymphocytes and classi-
cal infection models require previous T cell activation. In
this system, low transfection rates of T lymphocytes are
usually achieved but they were enough to induce full HIV
replication after stimulation with PHA or anti-CD3. One
open question in this model is whether p24-gag produc-
tion derives from plasmid driven transient virus produc-
tion and not yet full viral replication. Because T cell
activation induces both HIV integration and further pro-
viral transcription, full viral replication was achieved in
PHA and anti-CD3-activated T lymphocytes. Moreover,
increasing concentrations of p24-gag were detected
throughout culture time, thereby suggesting several cycles
of infection (Fig. 6). In this experimental system, inhibi-
tion of HIV replication by IκBα over-expression is proba-
bly produced during the first cycle of replication, because
in subsequent replication cycles IκBα will not be over-
expressed in non-transfected lymphocytes. Actually, a
delay in HIV spread in culture due to partial inhibition of
the first replication cycle in CMV-IκBα-transfected cells
was observed (Fig. 6). Moreover, decrease in p24-gag pro-
duction in CMV-IκBα-transfected cells was significant (p <
0.05) for resting and anti-CD3 activated T cells. Although
for PHA-activated lymphocytes this difference was not sig-
nificant, a five-fold decrease was observed at day 7 and a
trend towards statistical significance was found (p =
0.081). On the other hand, it is difficult to precise if the
mechanism involved in p24-gag production in non-acti-
vated T lymphocytes is due to plasmid-driven transient
virus production and not yet to viral replication. However,
our results showed a decrease in LTR transactivation (Fig.
5) and p24-gag production (Fig. 6) in resting CD4
+ T lym-
phocytes when IκBα is over-expressed. It suggests that
increasing IκBα levels in naturally HIV-infected CD4
+ T
lymphocytes carrying an integrated provirus could con-
tribute to NF-κB inhibition and subsequent low-level viral
production or absolute latency, as described in resting
CD4
+ T lymphocytes in vivo [12-14,30,31].
On the other hand, it has been described that HIV can
integrate into the genomes of in vitro-inoculated resting
CD4
+ T cells that have not received activating stimuli [32].
Accordingly, HIV replication can also start in these cells
although it cannot further progress unless these CD4
+ T
cells were subsequently activated and NF-κB activity were
maintained.
Overall, these data suggest that LTR transcriptional activa-
tion can be initiated by basal NF-κB activity in resting
CD4
+ T cells in the absence of previous stimuli. Alterna-
tively, the presence of high levels of nuclear IκBα would
result in NF-κB control and viral latency. These data are
supported by the existence of transdominant mutants of
IκBα that block NF-κB induction and inhibit de novo HIV
infection in T cells by interfering with viral transcription
[20,33]. Besides, control of IκBα by other cellular factors
such as Murr1, have been also involved in the mainte-
nance of HIV latency in resting CD4
+ T lymphocytes [34].Retrovirology 2007, 4:56 http://www.retrovirology.com/content/4/1/56
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HIV replication in resting or activated CD4
+ T cells transfected with an infectious molecular HIV-1 clone Figure 6
HIV replication in resting or activated CD4
+ T cells transfected with an infectious molecular HIV-1 clone. Highly 
purified CD4
+ CD25 
- CD69 
- DR- T cells were transfected with the NL4.3 infectious molecular HIV-1 clone together with CMV-
IκBα or pcDNA3.1 as negative control, and then activated with anti-CD3 and IL-2, PHA and IL-2, or maintained in the absence 
of activation. Viral replication was determined by quantification of HIV p24-gag antigen in culture supernatants (a) after 5 days 
of transfection or (b) after 7 days of transfection. Numbers on the top of the bars represent fold HIV-replication relative to 
unstimulated T cells transfected with pcDNA3.1. Differences in p24-gag production were significant for resting and anti-CD3-
activated T cells (p < 0.05) and a trend towards statistical significance was found in PHA-activated T cells (p = 0.081).
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Conclusion
The maintenance of HIV latency should be considered an
active cellular process. In resting CD4
+ T cells, both IκBα
and NF-κB are continuously shuttling between cytosol
and nucleus, as well as continuously associating and dis-
sociating to permit a low transcriptional activity necessary
for the activation of genes involved in cell survival. In rest-
ing HIV-infected T cells, the balance between free NF-κB
and NF-κB/IκBα complexes in the nucleus could directly
participate in the maintenance of HIV-latency when IκBα
predominates as well as in the low ongoing HIV replica-
tion when NF-κB escapes IκBα control. Both phenomena
have been characterized in vivo and constitute major path-
ogenic mechanisms in the persistence of long-lived cellu-
lar reservoirs of HIV [12-14,30,31]. Increased
understanding of the control of NF-κB activation and
repression would permit not only the development of
new strategies to stop active HIV replication but also alter-
native treatments aimed at reactivation of latent HIV res-
ervoirs in order to reduce them and contribute to viral
eradication.
Methods
Cells
Peripheral blood mononuclear cells (PBMCs) were iso-
lated from blood of healthy donors by centrifugation
through a Ficoll-Hypaque gradient (Pharmacia Corpora-
tion, North Peapack, NJ). Cells were collected in supple-
mented RPMI and maintained at a concentration of 2 ×
106 cells/ml. PHA-treated T lymphocytes were obtained
from PBMCs incubated for 3 days with 5 µg/ml phytohe-
magglutinin (PHA) (Sigma-Aldrich, St. Louis, MO) and
for the consecutive 9 days with 300 U/ml IL-2 (Chiron,
Emeryville, CA). These long-term cultures of PHA-treated
T lymphocytes were maintained without supplemental IL-
2 18 hours before the experiment. These PHA-treated T
lymphocytes remained at a pre-activated status and
expressed activation markers [35] although NF-κB did not
show DNA-binding activity (Additional file 2).
Resting CD4
+ T lymphocytes were isolated from PBMCs by
negative selection with CD4  Negative Isolation Kit (T
helper/inducer cells) (Dynal Biotech, Oslo, Norway),
according to the manufacturer's instructions. Subse-
quently, isolated CD4
+ T cells were depleted of CD25 
+ by
positive selection with Dynabeads CD25 (Dynal Biotech).
Purity of isolated CD4
+ CD25 
- T cells was analyzed by flow
cytometry with a FACScalibur flow cytometer (BD Bio-
sciences, Erembodegem, Belgium). Cells were stained
with monoclonal antibodies (mAb) against CD4  and
HLA-DR conjugated with fluorescein isothiocyanate
(FITC), and anti-CD25, -CD69, and -CD3 conjugated with
phycoerythrin (PE), all provided by BD Biosciences. Anal-
ysis by flow cytometry revealed that the phenotype of iso-
lated T lymphocytes was CD4
+ CD25 
- CD69 
- HLA-DR- with
a purity >95%.
Reagents and antibodies
Cells were incubated with 25 ng/ml of 5-phorbol 12-myr-
istate 13-acetate (PMA) (Sigma-Aldrich) for 30 min-18
hours. Leptomycin B (LMB) was used at 20 nM (Sigma-
Aldrich). Cells treated with 10 µg/ml of cycloheximide
(CHX) (Sigma-Aldrich) were incubated with this reagent
30 minutes before adding other stimuli. Primary antibod-
ies against p65/RelA, p105/p50 and IκBα were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA). Second-
ary antibodies conjugated to horseradish peroxidase were
purchased from GE Healthcare (Uppsala, Sweden). Sec-
ondary antibodies conjugated to Alexa 488 or Texas Red
were purchased from Molecular Probes (Eugene, OR).
Vectors
Luciferase reporter gene under the control of the U3+R
regions of the HIV-long terminal repeat (LTR) (LAI strain)
was previously reported [36]. pSV-β-Galactosidase vector
(Promega, Madison, WI) was used to cotransfect the cells
as an internal control reporter. IκBα gene cloned in
pcDNA3.1(+) vector under the control of CMV promoter
(CMV-IκBα) was described previously [37]. Viral Tat gene
under the control of the CMV promoter (CMV-Tat) was
also described previously [38]. pcDNA3.1(+) vector was
used as negative control (Invitrogen, Carlsbad, CA). The
vector pNL4.3 that contained the HIV complete genome
and induced an infectious progeny after transfection in
several cell lines was kindly provided by Dr M.A. Martin
[39; National Institute of health AIDS Research and Refer-
ence Reagent Program #3418]. Dr. Johannes Schmid
kindly provided the constructions of p65/RelA and IκBα
genes in the enhanced yellow fluorescent protein vector
(pEYFP-p65 and pEYFP-IκBα, respectively) [40,41].
Expression vector pEYFP-C1 (Clontech, BD Biosciences)
that contains the yellow fluorescent protein gene under
CMV promoter control was used as negative control. All
plasmids were purified using Qiagen Plasmid Maxi Kit
(Qiagen, CA), following the manufacturer's instructions.
Transfection assays
CD4
+ T cells (5 × 106) were transiently transfected with 2
µg of plasmid DNA under U-14 electroporation program
conditions by nucleoporation with an Amaxa Nucleofec-
tor (Amaxa, Cologne, Germany) according to the manu-
facturer's instructions. Alternatively, CD4
+ T cells were also
transfected by electroporation with an Easyjet Plus Elec-
troporator (Equibio, Middlesex, UK). In brief, 10 × 106
cells were resuspended in 350 µl of RPMI without supple-
ments and mixed with 1 µg of plasmid DNA per 106 cells
in a 4 mm electroporation cuvette (Equibio). Cells were
transfected at 320 V, 1500 µF and maximum resistance.
After transfection, cells were incubated in supplementedRetrovirology 2007, 4:56 http://www.retrovirology.com/content/4/1/56
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RPMI at 37°C for 24 hours before analysis. Luciferase and
β-Galactosidase activities were assayed using Luciferase
Assay System and β-Galactosidase Enzyme Assay System,
respectively, according to manufacture's instructions
(Promega).
Western blot assays
Cytosolic and nuclear protein extracts were obtained as
described previously [7]. Ten micrograms of nuclear
extracts were fractionated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred onto Hybond-ECL nitrocellulose paper (GE
Healthcare). After blocking and incubation with primary
and secondary antibodies, proteins were detected with
SuperSignal West Pico Chemiluminescent Substrate
(Pierce, Rockford, IL).
Immunoprecipitation assays
Cytosolic and nuclear protein extracts were subjected to
immunoprecipitation with agarose-conjugated antibody
against p65/RelA (Santa Cruz Biotechnology). In brief,
nuclear or cytosolic proteins (100 µg) were incubated
overnight at 4°C with 10 µg of specific agarose-conju-
gated antibody in RIPA buffer (PBS 1×, 0.1% SDS, 1% NP-
40) and 0.5% sodium deoxycholate (DOC). Immunopre-
cipitate was collected by centrifugation at 4°C, 2.500 rpm
for 5 minutes and washed four times with RIPA/DOC
buffer. Finally, the agarose pellet was denatured at 95°C
for 2 minutes and analyzed by SDS-PAGE, followed by
immunoblotting with the specific antibodies.
Electrophoretic mobility shift assays (EMSA)
Nuclear protein extracts (3 µg) were analyzed using the
[α-32P]-dCTP-labeled double-stranded synthetic wild-
type HIV enhancer oligonucleotide 5'-AGCTTACAAG-
GGACTTTCCGCTGGGGACTTTCCAGGGA-3' containing
both κB consensus motifs. The nucleoprotein-oligonucle-
otide complexes were analyzed by electrophoresis on a
non-denaturing 6% polyacrylamide gel.
HIV replication assay
Resting CD4
+ T cells were transfected with pNL4.3 vector
alone or with either CMV-IκBα or pcDNA3.1(+) vectors
and further activated with 1 µg/ml anti-CD3 (BD Bio-
sciences) plus 300 IU/ml IL-2. Viral replication was
assessed by quantification of HIV p24 gag antigen in cul-
ture supernatants every 48 hours using an enzyme-like
immunoassay (Innotest™ HIV Ag mAb, Innogenetics, Bar-
celona, Spain).
Confocal microscopy
For immunofluorescence assays, cells were immobilized
in PolyPrep slides (Sigma-Aldrich) for 15 minutes and
then fixed with 2% paraformaldehyde-0.025% glutaralde-
hyde in PBS for 10 minutes at room temperature. After
washing twice with 0.1% glycine/PBS, cells were permea-
bilized with 0.1% Triton ×-100/PBS for 10 minutes. After
washing, cells were treated with 1 mg/ml NaBH4 for 10
minutes. Incubation for 1 hour at room temperature with
each primary and secondary antibodies and subsequent
washes were performed with PBS/2% bovine serum albu-
min (BSA)/0.05% saponine buffer. Coverslips were
immobilized with 70% glycerol/PBS. Images were
obtained with a Radiance 2100 confocal microscope (Bio-
Rad, Hercules, CA). For time-lapse fluorescence confocal
microscopy, coverslips were coated with fibronectin (20
µg/ml) for 2 h at 37°C and blocked with PBS containing
BSA 0.1%. Then, coverslips were washed with 1× Hanks
Balanced Salt Solution (HBSS) and mounted in Attofluor
open chambers (Molecular Probes). Cells were allowed to
adhere on these chambers for 30 min. Confocal images
were acquired using a Leica TCS-SP Confocal Laser Scan-
ning Unit (Leica, Heidelberg, Germany) equipped with Ar
and He-Ne laser beams and attached to a Leica DMIRBE
Inverted Epi-Fluorescence Microscope. Images were proc-
essed and assembled into movies using Leica confocal
software.
Statistical analysis
Differences in HIV replication in the presence of IκBα
over-expression were assessed by Mann-Whitney test
using Statistical Product and Service Solutions (SPSS) soft-
ware v14 (Addlink Software Científico, Madrid, Spain).
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Additional file 1
Kinetic analysis of nuclear IκBα translocation. Movie of one CD4
+ T 
lymphocyte transfected with EYFP-IκBα vector photographed before and 
after treatment with LMB up to 30 minutes. Photographs were taken in 
vivo by confocal microscopy every minute after adding LMB. This movie 
corresponds to Figure 3, which has been constructed with some pictures 
taken at different moments before and after adding LMB. It is an .avi file 
that can be viewed with Windows Media Player.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1742-
4690-4-56-S1.avi]
Additional file 2
Absence of NF-κB binding activity in nuclear protein extracts from 
unstimulated PHA-treated T cells. (a) Binding of NF-κB in nuclear 
extracts from PHA-treated T cells to its cognate DNA sequence was ana-
lyzed. PBMCs were cultured for 3 days with 5 µg/ml PHA and for the con-
secutive 9 days with 300 U/ml IL-2. These long-term cultures of PHA-
treated T lymphocytes were maintained without supplemental IL-2 18 
hours. Three micrograms of nuclear extracts from IL-2 depleted T cells 
(lane 1) and activated with PMA for 30 min or 5 hours (lanes 2 and 3, 
respectively) were incubated with an oligonucleotide containing double -
κB consensus motif from HIV LTR labeled with [α-32P]-dCTP. (b) Anal-
ysis of the NF-κB complexes composition by supershift assay. Three micro-
grams of nuclear extracts from PHA-treated T cells activated with PMA 
for 2 hours were incubated with antibodies against p50/NF-κB1 (lane 3), 
p65/RelA (lane 4) or c-Rel (lane 5) before the incubation with an oligo-
nucleotide containing double -κB consensus motif from HIV LTR labeled 
with [α-32P]-dCTP. Lane 2 shows the specificity of binding of the NF-κB 
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[http://www.biomedcentral.com/content/supplementary/1742-
4690-4-56-S2.ppt]Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Retrovirology 2007, 4:56 http://www.retrovirology.com/content/4/1/56
Page 13 of 13
(page number not for citation purposes)
27. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE,
Quinn TC, Chadwick K, Margolick J, Brookmeyer R, Gallant J,
Markowitz M, Ho DD, Richman DD, Siliciano RF: Identification of
a reservoir for HIV-1 in patients on highly active antiretrovi-
ral therapy.  Science 1997, 278:1295-1300.
28. Wong JK, Hezareh M, Gunthard HF, Havlir DV, Ignacio CC, Spina CA,
Richman DD: Recovery of replication-competent HIV despite
prolonged suppression of plasma viremia.  Science 1997,
278:1291-1295.
29. Kinter AL, Umscheid CA, Arthos J, Cicala C, Lin Y, Jackson R, Dono-
ghue E, Ehler L, Adelsberger J, Rabin RL, Fauci AS: HIV envelope
induces virus expression from resting CD4+ T cells isolated
from HIV-infected individuals in the absence of markers of
cellular activation or apoptosis.  J Immunol 2003, 170:2449-2455.
30. Lassen KG, Bailey JR, Siliciano RF: Analysis of human immunode-
ficiency virus type 1 transcriptional elongation in resting
CD4+ T cells in vivo.  J Virol 2004, 78:9105-9114.
31. Zhang ZQ, Wietgrefe SW, Li Q, Shore MD, Duan L, Reilly C, Lifson
JD, Haase AT: Roles of substrate availability and infection of
resting and activated CD4+ T cells in transmission and acute
simian immunodeficiency virus infection.  Proc Natl Acad Sci USA
2004, 101:5640-5645.
32. Swiggard WJ, Baytop C, Yu JJ, Dai J, Li C, Schretzenmair R, Theod-
osopoulos T, O'Doherty U: Human immunodeficiency virus
type 1 can establish latent infection in resting CD4+ T cells
in the absence of activating stimuli.  J Virol 2005,
79:14179-14188.
33. Kwon H, Pelletier N, DeLuca C, Genin P, Cisternas S, Lin R, Wain-
berg MA, Hiscott J: Inducible expression of IκBα repressor
mutants interferes with NF-κB activity and HIV-1 replication
in Jurkat T cells.  J Biol Chem 1998, 273:7431-7440.
34. Ganesh L, Burstein E, Guha-Niyogi A, Louder MK, Mascola JR, Klomp
LW, Wijmenga C, Duckett CS, Nabel GJ: The gene product Murr1
restricts HIV-1 replication in resting CD4+ lymphocytes.
Nature 2003, 426:853-857.
35. Li ZW, Rickert RC, Karin M: Genetic dissection of antigen
receptor induced-NF-kappaB activation.  Mol Immunol 2004,
41:701-714.
36. Bachelerie F, Alcamí J, Arenzana-Seisdedos F, Virelizier JL: HIV
enhancer activity perpetuated by NF-kappaB induction on
infection of monocytes.  Nature 1991, 350:709-712.
37. Rodríguez MS, Michalopoulos I, Arenzana-Seisdedos F, Hay RT:
Inducible degradation of IκBα in vitro and in vivo requires
the acidic C-terminal domain of the protein.  Mol Cell Biol 1995,
15:2413-2419.
38. Malim MH, Hauber J, Fenrick R, Cullen BR: Immunodeficiency
virus rev trans-activator modulates the expression of the
viral regulatory genes.  Nature 1988, 335:181-183.
39. Adachi A, Gendelman HE, Koening S, Folks T, Willey R, Rabson A,
Martin MA: Production of acquired immunodeficiency syn-
drome-associated retrovirus in human and non-human cells
transfected with an infectious molecular clone.  J Virol 1988,
59:284-291.
40. Schmid JA, Birbach A, Hofer-Warbinek R, Pengg M, Burner U, Furt-
muller PG, Binder BR, de Martin R: Dynamics of NF kappa B and
Ikappa Balpha studied with green fluorescent protein (GFP)
fusion proteins. Investigation of GFP-p65 binding to DNA by
fluorescence resonance energy transfer.  J Biol Chem 2000,
275:17035-17042.
41. Birbach A, Gold P, Binder BR, Hofer E, de Martin R, Schmid JA: Sig-
naling molecules of the NF-kappa B pathway shuttle consti-
tutively between cytoplasm and nucleus.  J Biol Chem 2002,
277:10842-10851.